Efficacy and safety of gemcitabine-docetaxel combination therapy for recurrent or refractory high-grade osteosarcoma in China: A retrospective study of 18 patients

Japanese Journal of Clinical Oncology

Volumn 42, Issue 5, 2012, Pages 427-431

  Qi, Wei Xiang ^a   He, Ai Na ^a   Tang, Li Na ^a   Shen, Zan ^a   Lin, Feng ^a   Yao, Yang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Docetaxel; Gemcitabine; Osteosarcoma; Salvage chemotherapy

Indexed keywords

CISPLATIN; DEXAMETHASONE; DOCETAXEL; DOXORUBICIN; GEMCITABINE; IFOSFAMIDE; METHOTREXATE; ONDANSETRON;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; ALOPECIA; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER GRADING; CANCER GROWTH; CANCER SURVIVAL; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CHILD; CHINA; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; HUMAN; KIDNEY FUNCTION; LEUKOPENIA; LIVER FUNCTION; MALE; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; OSTEOSARCOMA; OVERALL SURVIVAL; PATIENT ASSESSMENT; RECURRENT CANCER; RETROSPECTIVE STUDY; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHINA; DEOXYCYTIDINE; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; OSTEOSARCOMA; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TAXOIDS; TREATMENT OUTCOME;

EID: 84860489393     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hys030     Document Type: Article

References (18)

1. Nagarajan R, Weigel BJ, Thompson RC, Perentesis JP. Osteosarcoma in the first decade of life. Med Pediatr Oncol 2003;41:480-3.
2. Bramwell VH, Burgers M, Sneath R, et al. A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup. J Clin Oncol 1992;10:1579-91.
3. Bacci G, Picci P, Ferrari S, et al. Primary chemotherapy and delayed surgery for non metastatic osteosarcoma of the extremity: results in 164 patients preoperatively treated with high doses of methotrexate, followed by cisplatin and doxorubicin. Cancer 1993;72:1216-26.
4. Provisor AJ, Ettinger LJ, Nachman JB, et al. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol 1997;15:76-84.
5. Fuchs N, Bielack SS, Epler D, et al. Long-term results of the cooperative German-Austrian-Swiss Osteosarcoma Study Group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol 1998;9:893-9.
6. Gandhi V, Legha J, Chen F, Hertel LW, Plunkett W. Excision of 20,20-difluorodeoxycytidine (gemcitabine) monophosphate residues from DNA. Cancer Res 1996;56:4453-9.
7. Ringel I, Horwitz SB. Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol. J Natl Cancer Inst 1991;83:288-91.
8. Leu KM, Ostruszka LJ, Shewach D, et al. Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of sarcoma. J Clin Oncol 2004;22:1706-12.
9. Ricotti L, Tesei A, De Paola F, et al. In vitro schedule-dependent interaction between docetaxel and gemcitabine in human gastric cancer cell lines. Clin Cancer Res 2003;9:900-5.
10. Mora J, Cruz CO, Parareda A, de Torres C. Treatment of relapsed/refractory pediatric sarcomas with gemcitabine and docetaxel. J Pediatr Hematol Oncol 2009;31:723-9.
11. Okuno S, Edmonson J, Mahoney M, Buckner JC, Frytak S, Galanis E. Phase II trial of gemcitabine in advanced sarcomas. Cancer 2002;94:3225-9.
12. Maki RG, Wathen JK, Patel SR, et al. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002. J Clin Oncol 2007;25:2755-63.
13. Hensley ML, Maki R, Venkatraman E, et al. Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol 2002;20:2824-31.
14. Ebeling P, Eisele L, Schuett P, et al. Docetaxel and gemcitabine in the treatment of soft tissue sarcoma-a single-center experience. Onkologie 2008;31:11-6.
15. Lin F, Wang Q, Yu W, et al. Clinical analysis of Chinese limb osteosarcoma patients treated by two combinations of methotrexate, cisplatin, doxorubicin and ifosfamide. Asia Pac J Clin Oncol 2011;7:270-5.
16. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-16.
17. McTiernan A, Whelan JS. A phase II study of docetaxel for the treatment of recurrent osteosarcoma. Sarcoma 2004;8:71-6.
18. Navid F, Willert JR, McCarville MB, et al. Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma. Cancer 2008;113:419-25.